Necrotizing Fasciitis Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: NB9D9EF9C456EN
Market Monitor Global

Abstracts

Necrotizing Fasciitis is rare but serious bacterial infection commonly known as flesh eating disease which affects the tissue beneath the skin and surrounding organs and muscles.

This report contains market size and forecasts of Necrotizing Fasciitis Drug in Global, including the following market information:

Global Necrotizing Fasciitis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Necrotizing Fasciitis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Aminoglycoside Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Necrotizing Fasciitis Drug include GlaxoSmithKline, Pfizer, Bristol-Myers Squibb, Merck, Abbott, Teva, WOCKHARDT, Atox Bio and Basilea Pharmaceutica and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Necrotizing Fasciitis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Necrotizing Fasciitis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Necrotizing Fasciitis Drug Market Segment Percentages, by Type, 2021 (%)

• Aminoglycoside
• Metronidazole
• Clindamycin
• Fluoroconazoles
• Others

Global Necrotizing Fasciitis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Necrotizing Fasciitis Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Online Pharnacies
• Retail Pharmacies

Global Necrotizing Fasciitis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Necrotizing Fasciitis Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Necrotizing Fasciitis Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Necrotizing Fasciitis Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Pfizer
• Bristol-Myers Squibb
• Merck
• Abbott
• Teva
• WOCKHARDT
• Atox Bio
• Basilea Pharmaceutica
• MELINTA THERAPEUTICS

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Necrotizing Fasciitis Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Necrotizing Fasciitis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NECROTIZING FASCIITIS DRUG OVERALL MARKET SIZE

2.1 Global Necrotizing Fasciitis Drug Market Size: 2021 VS 2028
2.2 Global Necrotizing Fasciitis Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Necrotizing Fasciitis Drug Players in Global Market
3.2 Top Global Necrotizing Fasciitis Drug Companies Ranked by Revenue
3.3 Global Necrotizing Fasciitis Drug Revenue by Companies
3.4 Top 3 and Top 5 Necrotizing Fasciitis Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Necrotizing Fasciitis Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Necrotizing Fasciitis Drug Players in Global Market
  3.6.1 List of Global Tier 1 Necrotizing Fasciitis Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Necrotizing Fasciitis Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Necrotizing Fasciitis Drug Market Size Markets, 2021 & 2028
  4.1.2 Aminoglycoside
  4.1.3 Metronidazole
  4.1.4 Clindamycin
  4.1.5 Fluoroconazoles
  4.1.6 Others
4.2 By Type - Global Necrotizing Fasciitis Drug Revenue & Forecasts
  4.2.1 By Type - Global Necrotizing Fasciitis Drug Revenue, 2017-2022
  4.2.2 By Type - Global Necrotizing Fasciitis Drug Revenue, 2023-2028
  4.2.3 By Type - Global Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Necrotizing Fasciitis Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Online Pharnacies
  5.1.4 Retail Pharmacies
5.2 By Application - Global Necrotizing Fasciitis Drug Revenue & Forecasts
  5.2.1 By Application - Global Necrotizing Fasciitis Drug Revenue, 2017-2022
  5.2.2 By Application - Global Necrotizing Fasciitis Drug Revenue, 2023-2028
  5.2.3 By Application - Global Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Necrotizing Fasciitis Drug Market Size, 2021 & 2028
6.2 By Region - Global Necrotizing Fasciitis Drug Revenue & Forecasts
  6.2.1 By Region - Global Necrotizing Fasciitis Drug Revenue, 2017-2022
  6.2.2 By Region - Global Necrotizing Fasciitis Drug Revenue, 2023-2028
  6.2.3 By Region - Global Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Necrotizing Fasciitis Drug Revenue, 2017-2028
  6.3.2 US Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.3.3 Canada Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.3.4 Mexico Necrotizing Fasciitis Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Necrotizing Fasciitis Drug Revenue, 2017-2028
  6.4.2 Germany Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.4.3 France Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.4.4 U.K. Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.4.5 Italy Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.4.6 Russia Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.4.8 Benelux Necrotizing Fasciitis Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Necrotizing Fasciitis Drug Revenue, 2017-2028
  6.5.2 China Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.5.3 Japan Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.5.4 South Korea Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.5.6 India Necrotizing Fasciitis Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Necrotizing Fasciitis Drug Revenue, 2017-2028
  6.6.2 Brazil Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.6.3 Argentina Necrotizing Fasciitis Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Necrotizing Fasciitis Drug Revenue, 2017-2028
  6.7.2 Turkey Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.7.3 Israel Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Necrotizing Fasciitis Drug Market Size, 2017-2028
  6.7.5 UAE Necrotizing Fasciitis Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Necrotizing Fasciitis Drug Major Product Offerings
  7.1.4 GlaxoSmithKline Necrotizing Fasciitis Drug Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Necrotizing Fasciitis Drug Major Product Offerings
  7.2.4 Pfizer Necrotizing Fasciitis Drug Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Necrotizing Fasciitis Drug Major Product Offerings
  7.3.4 Bristol-Myers Squibb Necrotizing Fasciitis Drug Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Necrotizing Fasciitis Drug Major Product Offerings
  7.4.4 Merck Necrotizing Fasciitis Drug Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Abbott
  7.5.1 Abbott Corporate Summary
  7.5.2 Abbott Business Overview
  7.5.3 Abbott Necrotizing Fasciitis Drug Major Product Offerings
  7.5.4 Abbott Necrotizing Fasciitis Drug Revenue in Global Market (2017-2022)
  7.5.5 Abbott Key News
7.6 Teva
  7.6.1 Teva Corporate Summary
  7.6.2 Teva Business Overview
  7.6.3 Teva Necrotizing Fasciitis Drug Major Product Offerings
  7.6.4 Teva Necrotizing Fasciitis Drug Revenue in Global Market (2017-2022)
  7.6.5 Teva Key News
7.7 WOCKHARDT
  7.7.1 WOCKHARDT Corporate Summary
  7.7.2 WOCKHARDT Business Overview
  7.7.3 WOCKHARDT Necrotizing Fasciitis Drug Major Product Offerings
  7.7.4 WOCKHARDT Necrotizing Fasciitis Drug Revenue in Global Market (2017-2022)
  7.7.5 WOCKHARDT Key News
7.8 Atox Bio
  7.8.1 Atox Bio Corporate Summary
  7.8.2 Atox Bio Business Overview
  7.8.3 Atox Bio Necrotizing Fasciitis Drug Major Product Offerings
  7.8.4 Atox Bio Necrotizing Fasciitis Drug Revenue in Global Market (2017-2022)
  7.8.5 Atox Bio Key News
7.9 Basilea Pharmaceutica
  7.9.1 Basilea Pharmaceutica Corporate Summary
  7.9.2 Basilea Pharmaceutica Business Overview
  7.9.3 Basilea Pharmaceutica Necrotizing Fasciitis Drug Major Product Offerings
  7.9.4 Basilea Pharmaceutica Necrotizing Fasciitis Drug Revenue in Global Market (2017-2022)
  7.9.5 Basilea Pharmaceutica Key News
7.10 MELINTA THERAPEUTICS
  7.10.1 MELINTA THERAPEUTICS Corporate Summary
  7.10.2 MELINTA THERAPEUTICS Business Overview
  7.10.3 MELINTA THERAPEUTICS Necrotizing Fasciitis Drug Major Product Offerings
  7.10.4 MELINTA THERAPEUTICS Necrotizing Fasciitis Drug Revenue in Global Market (2017-2022)
  7.10.5 MELINTA THERAPEUTICS Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Necrotizing Fasciitis Drug Market Opportunities & Trends in Global Market
Table 2. Necrotizing Fasciitis Drug Market Drivers in Global Market
Table 3. Necrotizing Fasciitis Drug Market Restraints in Global Market
Table 4. Key Players of Necrotizing Fasciitis Drug in Global Market
Table 5. Top Necrotizing Fasciitis Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Necrotizing Fasciitis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Necrotizing Fasciitis Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Necrotizing Fasciitis Drug Product Type
Table 9. List of Global Tier 1 Necrotizing Fasciitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Necrotizing Fasciitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Necrotizing Fasciitis Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Necrotizing Fasciitis Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Necrotizing Fasciitis Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Necrotizing Fasciitis Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Necrotizing Fasciitis Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Necrotizing Fasciitis Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Necrotizing Fasciitis Drug Product Offerings
Table 32. GlaxoSmithKline Necrotizing Fasciitis Drug Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Necrotizing Fasciitis Drug Product Offerings
Table 35. Pfizer Necrotizing Fasciitis Drug Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Necrotizing Fasciitis Drug Product Offerings
Table 38. Bristol-Myers Squibb Necrotizing Fasciitis Drug Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Necrotizing Fasciitis Drug Product Offerings
Table 41. Merck Necrotizing Fasciitis Drug Revenue (US$, Mn), (2017-2022)
Table 42. Abbott Corporate Summary
Table 43. Abbott Necrotizing Fasciitis Drug Product Offerings
Table 44. Abbott Necrotizing Fasciitis Drug Revenue (US$, Mn), (2017-2022)
Table 45. Teva Corporate Summary
Table 46. Teva Necrotizing Fasciitis Drug Product Offerings
Table 47. Teva Necrotizing Fasciitis Drug Revenue (US$, Mn), (2017-2022)
Table 48. WOCKHARDT Corporate Summary
Table 49. WOCKHARDT Necrotizing Fasciitis Drug Product Offerings
Table 50. WOCKHARDT Necrotizing Fasciitis Drug Revenue (US$, Mn), (2017-2022)
Table 51. Atox Bio Corporate Summary
Table 52. Atox Bio Necrotizing Fasciitis Drug Product Offerings
Table 53. Atox Bio Necrotizing Fasciitis Drug Revenue (US$, Mn), (2017-2022)
Table 54. Basilea Pharmaceutica Corporate Summary
Table 55. Basilea Pharmaceutica Necrotizing Fasciitis Drug Product Offerings
Table 56. Basilea Pharmaceutica Necrotizing Fasciitis Drug Revenue (US$, Mn), (2017-2022)
Table 57. MELINTA THERAPEUTICS Corporate Summary
Table 58. MELINTA THERAPEUTICS Necrotizing Fasciitis Drug Product Offerings
Table 59. MELINTA THERAPEUTICS Necrotizing Fasciitis Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Necrotizing Fasciitis Drug Segment by Type in 2021
Figure 2. Necrotizing Fasciitis Drug Segment by Application in 2021
Figure 3. Global Necrotizing Fasciitis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Necrotizing Fasciitis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Necrotizing Fasciitis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Necrotizing Fasciitis Drug Revenue in 2021
Figure 8. By Type - Global Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028
Figure 12. US Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028
Figure 16. Germany Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028
Figure 24. China Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Necrotizing Fasciitis Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Necrotizing Fasciitis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Necrotizing Fasciitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Necrotizing Fasciitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Necrotizing Fasciitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Necrotizing Fasciitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbott Necrotizing Fasciitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Teva Necrotizing Fasciitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. WOCKHARDT Necrotizing Fasciitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Atox Bio Necrotizing Fasciitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Basilea Pharmaceutica Necrotizing Fasciitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. MELINTA THERAPEUTICS Necrotizing Fasciitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)